Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Circulating microRNAs as biomarkers for disease staging in multiple sclerosis.
Country, Sex, EDSS Change and Therapy Choice Independently Predict Treatment Discontinuation in Multiple Sclerosis and Clinically Isolated Syndrome.
Impact of anti-rheumatic treatment on immunogenicity of pandemic H1N1 influenza vaccine in patients with arthritis.
Glatiramer acetate (copaxone) modulates platelet activation and inhibits thrombin-induced calcium influx: possible role of copaxone in targeting platelets during autoimmune neuroinflammation.
First use of alemtuzumab in Balo's concentric sclerosis: a case report.
A genome screen for multiple sclerosis in Italian families.
Ceramide Synthase 6 Plays a Critical Role in the Development of Experimental Autoimmune Encephalomyelitis.
A randomized trial of high-dose vitamin D2 in relapsing-remitting multiple sclerosis.
Suppression of Murine Experimental Autoimmune Optic Neuritis by Mature Dendritic Cells Transfected with Calcitonin Gene-Related Peptide Gene.
Long-term clinical and magnetic resonance imaging outcomes from patients treated with teriflunomide: Results from a phase 2 extension study.
A phase IIa randomised clinical study of GNbAC1, a humanised monoclonal antibody against the envelope protein of multiple sclerosis-associated endogenous retrovirus in multiple sclerosis patients.
Multiple sclerosis susceptibility genes: associations with relapse severity and recovery.
Alpha4-integrin antagonism--an effective approach for the treatment of inflammatory diseases?
Development of the Brief Inventory of Perceived Stress.
VLA-4 blockade promotes differential routes into human CNS involving PSGL-1 rolling of T cells and MCAM-adhesion of TH17 cells.
Evaluation of an electronic diary for improvement of adherence to interferon beta-1b in patients with multiple sclerosis: design and baseline results of an observational cohort study.
"Undiagnosing" multiple sclerosis: The challenge of misdiagnosis in MS.
Siponimod (BAF312) for the treatment of secondary progressive multiple sclerosis: Design of the phase 3 EXPAND trial.
Helminth therapy and multiple sclerosis.
Comparative efficacy of fingolimod vs natalizumab: A French multicenter observational study.
Pilates based core stability training in ambulant individuals with multiple sclerosis: Protocol for a multi-centre randomised controlled trial.
CHMP assessment report for Sovrima (International nonproprietary name: idebenone)
Galectin-1 for neuroprotection?
Diffuse and heterogeneous T2-hyperintense lesions in the splenium are characteristic of neuromyelitis optica.
Relationships between retinal axonal and neuronal measures and global central nervous system pathology in multiple sclerosis.

Pages